INTRODUCTION
TLRs sense microbes or host "alarmins" to activate innate immunity and orchestrate adaptive immune responses. 1 TLRs present on the plasma membrane (TLR1, TLR5, TLR6), endosomes (TLR3, TLR7, TLR9), or in both compartments (TLR2, TLR4) in myeloid cells express an ectodomain involved in ligand recognition, a transmembrane segment, and an intracellular Toll-IL-1R (TIR) signaling domain. 1, 2 Upon ligand recognition, the majority of TLRs recruit myeloid differentiation primary response protein (MyD) 88, followed by recruitment of and TLR4 signal from endosomes via TIR domain-containing adapter inducing IFN-(TRIF) that recruits TRAF-associated NF-B activatorbinding kinase-1 and IKK-. These kinases activate IFN regulatory factor (IRF)-3, leading to its nuclear translocation and transcription of type I IFNs. 2 The TRIF pathway also mediates delayed activation of MAPKs and NF-B via the receptor-interacting protein-1-TRAF6 signaling axis. 2 Studies with IL-1 and defined TLR agonists have revealed that activated IRAK4 signals via the TAK1-IKK-axis to mediate classical activation of NF-B, engages the MK2-dependent pathway to stabilize cytokine mRNAs, 4, 6, 7 and elicits rapid activation of nucleotide-binding and oligomerization domain-like receptor containing pyrin domain 3 (NLRP3) inflammasome. 8, 9 Kinase-inactive (K213M) IRAK4 (IRAK4 KI ) fails to mediate these responses, 10 but signals via MAPK-ERK kinase 3 (MEKK3)-IKK-to trigger non-classical activation of NF-B. This pathway up-regulates cytokines (e.g., CCL 2, CCL4, CCL7), signaling molecules (TLR2, IRAK2), and TLR inhibitors (A20, IRAK-M) whose expression is not regulated by mRNA stability. 4, 6, 7, [10] [11] [12] [13] Macrophages and mice harboring IRAK4 KI are deficient in mounting responses to and containing infection with Streptococcus pneumoniae, 13 
MATERIALS AND METHODS

Abs and reagents
The following Abs were used: anti-phospho (p)-IRAK1, anti-IRAK1, anti-p65 NF-B (Santa Cruz Biotechnology, Santa Cruz, CA); anti-p- 
Mice, infection, and macrophage isolation
C57BL/6J mice were from the Jackson Laboratory (Bar Harbor, ME).
IRAK4 KI mice 7, 8, 10, 12, 13 were provided by Drs. Kirk Staschke (Eli Lilly, Indianapolis, IN) and Stefanie Vogel (University of Maryland School of Medicine, Baltimore, MD). Mice were housed in the University of Connecticut Health Center animal facility, and 6-week-old male and female mice were used. All animal procedures were approved by the Institutional Animal Care and Use Committee. For infections, wild-type (WT) or IRAK4 KI mice were i.p. administered M. smegmatis (5 × 10 6 CFUs) or L. monocytogenes (2 × 10 4 CFU), similar to doses used in previous reports. 16, 17 Six hours post infection (hpi), blood samples were obtained by retroorbital punctures and serum was prepared to analyze cytokines. At 48 hpi, spleens and livers were homogenized in PBS containing protease and phosphatase inhibitors (ThermoFisher Scientific, Waltham, MA) and bacterial CFUs were enumerated by plating organ homogenates on the respective agars. 16, 18 To generate bone marrow-derived macrophages (BMDMs), bone marrow cells from femurs and tibias were differentiated for 7 days in DMEM (Mediatech, Herndon, VA), supplemented with 10% FBS (Atlanta Biologicals, Flowery Branch, GA), 2 mM L-glutamine, 100 U/ml penicillin, 100 g/ml streptomycin (complete RPMI) and 15% L929 cell-conditioned, macrophage-colony-stimulating factorcontaining supernatant. 6 2 mM L-glutamine, 100 U/ml penicillin, 100 g/ml streptomycin, and 100 g/ml gentamycin.
Bacterial cultures and infection
Assessment of bacterial CFUs
BMDMs were grown overnight in 24-well plates (10 6 was determined by plating 10-fold serial dilutions of lysates on Middlebrook 7H10 plates complemented with 0.5% glycerol, 10% OADC enrichment, 40 g/ml kanamycin (M. smegmatis) or blood heart infusion agar plates containing 10 g/ml chloramphenicol (L. monocytogenes). 19 Plates were incubated at 37 • C and CFUs were counted after 24-48 h. 
Analyses of bacterial uptake by flow cytometry
Isolation of RNA and real-time PCR
RNA was extracted with TRIzol (ThermoFisher Scientific), cDNA was prepared from 1 g of total RNA using the reverse transcription system (Promega, Madison, WI, USA) and analyzed by real-time PCR on a MyIQ real-time PCR machine (Bio-Rad). The following primers were used-Gapdh:
The data were calculated as a ratio of expression of gene of interest normalized to that of Gapdh, normalized to medium treatments and expressed as folds induction. 12
Western blot analyses
Cells were lysed in lysis buffer (50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1% Triton X-100, 1 mM EDTA, 5 mM NaF, 2 mM sodium orthovanadate, 1 mM PMSF, 1× complete protease inhibitors), and resuspended in Laemmli buffer (50 mm Tris-Cl, pH 6.8, 10% glycerol, 2% SDS, 0.1% bromophenol blue, 5% 2-mercaptoethanol), boiled for 5 min, separated on 4-20% polyacrylamide gels (ThermoFisher Scientific), transferred to polyvinylidene fluoride membranes (Bio-Rad), blocked, and probed with the respective Abs, as described. 12 
Analyses of cytokine secretion and NO release
Organ homogenates and supernatants from cell stimulated with TLR agonists or infected with bacteria were cleared by centrifugation (400 × 1,000 g, 10 min), and cytokine levels were determined by ELISA using commercial kits (BioLegend, San Diego, CA) per manufacturer's recommendations. The ELISA kits had the following limits of detection: 16 pg/ml (IL-1 ), 4 pg/ml (TNF-, IL-6, and CXCL1), and 31.20 pg/ml (CCL5). Nitrite (NO2 − ; product of NO breakdown) concentrations in the supernatants were examined by the Griess method. 20 NO2 − was quantified using sodium nitrite (NaNO 2 )
as a standard.
Statistical analysis
Data were processed by the GraphPad Prism software package (GraphPad Software, San Diego, CA), using one-way ANOVA with the Tukey's post-hoc test to compare multiple experimental groups, or using Student's t-test to perform pair-way comparisons, and the data were expressed as mean ± SD.
RESULTS
Macrophages expressing IRAK4 KI show reduced expression of cytokines upon infection with L. monocytogenes or M. smegmatis
In response to TLR/IL-1R agonists, IRAK4 kinase activity is prerequisite for induction of inflammatory mediators whose expression is regulated by mRNA stability 4,6,7,10-13 and for host resistance against S. pneumoniae, 13 and phosphorylation of p38 MAPK and p65 NF-B, whereas these responses were markedly attenuated in IRAK4 KI BMDMs (Fig. 3A ).
During infection with M. smegmatis, WT, but not IRAK4 KI , BMDMs exhibited efficient phosphorylation of IRAK1, ERK and p38 MAPKs and p65 NF-B (Fig. 3B) . Notably, IRAK4-independent, TRIF-driven 21 phosphorylation of IRF3 was induced comparably in WT and IRAK4 KI BMDMs (Fig. 3C) . These results indicate that deficiency in IRAK4 infections in mice subjected to pharmacologic inhibition of iNOS or in carriers of polymorphisms rendering the enzyme dysfunctional. 24, 27, 28 While MyD88 is required for NO production, 29 smegmatis by production of NO, suggesting their deficient microbicidal functions.
Increased microbial loads in IRAK4 KI BMDMs infected with L. monocytogenes or M. smegmatis
In the next series of experiments, we examined whether deficient NO 
DISCUSSION
IRAK4 integrates signaling emanating from the majority of TLRs, except TLR3, to trigger induction of inflammatory cytokine genes, and mediates rapid, transcription-independent activation of NLRP3 inflammasome. 2, 4, [6] [7] [8] [9] Human IRAK4-deficient patients have recurrent pyogenic infection, 30, 31 and IRAK4 −/− mice succumb to infections with S. aureus or S. pneumoniae. 13, 15, 32 In response to defined IL-1R/TLR ligands, IRAK4 activity is required to induce cytokines whose expression is regulated by mRNA stability, and to optimally activate MAPKs and NF-B via the TAK1-IKK pathway. 4 ,6,7,10-13
Kinase-inactive IRAK4 adapter triggers MEKK3-dependent activation of IKK-and IKK-, which initiates I B-phosphorylation without degradation and induces a subset of cytokines (CCL2, CCL4, CXCL10) and negative regulators (IRAK-M, A20). 4, 6, 7, [10] [11] [12] [13] Although IRAK4 kinase deficiency renders mouse macrophages hyporesponsive to extracellular bacteria S. aureus or S. pneumoniae and conferred increased susceptibility to S. pneumoniae infection in mice, 13 or TLR9 (bacterial DNA). [33] [34] [35] [36] [37] These TLRs activate IRAK4 enzymatic activity to induce IRAK4-dependent phosphorylation and activation of IRAK1. [3] [4] [5] In line with the requirement for IRAK4 to activate IRAK1, [3] [4] [5] we observed deficient IRAK4 and IRAK1 phosphorylation and reduced Of note, WT and IRAK4 KI -expressing BMDMs exhibited comparable phosphorylation of TRIF-dependent IRF3, indicating a tailored impact of IRAK4 kinase activity primarily on MyD88-dependent signaling cascades, in line with previous findings. 12, 13 We also demonstrate herein different dependence on IRAK4 kinase activity for the induction of various cytokines in infected macrophages, with strict dependence for TNF-, IL-6, and IL-1 and lower dependency for CCL5.
Sensing of mycobacterial species and L. monocytogenes involves several sensors, for example, TLR2, TLR3, TLR4, TLR7, and TLR9 that engage MyD88-IRAK4-driven and the TRIF-dependent pathways. 20, 22, 33, [37] [38] [39] As CCL5 can be induced via the TRIF pathway 21 that does not utilize IRAK4, whereas TNF-, IL-6, and IL-1 rely primarily on the MyD88-IRAK4 module, 40 this could explain the observed differences.
Furthermore, IRAK4 kinase activity is required to stabilize mRNA for several cytokines, for example, TNF-, IL-6, IL-1 , while CCL5 induction could be less dependent on mRNA stabilization, analogous to other cytokines (CCL2, CCL4, CCL7). 6 We also do not exclude that NO is one of the major bactericidal mediators involved in host defense against L. monocytogenes and mycobacterial species, 18, 20, [22] [23] [24] [25] [26] and genetic mutations in iNOS or its pharmacologic inhibition have been linked to listeriosis and mycobacterial infections. 24, 27, 28 NO production requires MyD88, 29 Previous reports demonstrated the requirement of TLR2 and
MyD88 for restricting intracellular replication of Coxiella burnetii, 44, 45 and enhanced growth of Legionella pneumophilla in the lung of MyD88 −/− mice. 46 
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